Not only does this add weight to the hypothesis that perturbations in adenosine metabolism are linked to the development of pulmonary abnormalities in ADA deficiency, but it also suggests that current therapies may not be sufficiently controlling and/or preventing pulmonary abnormalities in ADA deficiency. The gene discussed is ADA; the disease is hyperinsulinemic hypoglycemia, familial, 4.